Unveiling the Layers of HPV Vaccine Acceptance Among Men
HPV, or the human papillomavirus, is a prevalent sexually transmitted infection with significant health implications for both men and women. While the focus of HPV vaccination campaigns has predominantly been on women, the recent study sheds light on the acceptability of the HPV vaccine among men.
The Source Article Details
Cited By: 114 (Updated: December 4, 2023)
The Source Article's Abstract
ObjectiveTo understand rates of human papillomavirus (HPV) vaccine acceptability and factors correlated with HPV vaccine acceptability.
DesignMeta-analyses of cross-sectional studies.
Conclusions Public health campaigns that promote positive HPV vaccine attitudes and awareness about HPV risk in men, and interventions to promote healthcare provider recommendation of HPV vaccination for boys and mitigate obstacles due to cost and logistical barriers may support HPV vaccine acceptability for men. Future investigations employing rigorous designs, including intervention studies, are needed to support effective HPV vaccine promotion among men.
The Source Article References
- Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men by Palefsky, 2005 in AIDS
- Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men by Goldstone, 2011 in J Infect Dis
- Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study by Nyitray, 2011 in J Infect Dis
- Sexually transmitted infection as a cause of anal cancer by Frisch, 1997 in N Eng J Med
- Human papillomavirus-associated cancers in human with human immunodeficiency virus and acquired immunodeficiency syndromes by Frisch, 2000 in J Natl Cancer Inst
- Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men by Reiter, 2010 in Sex Transm Infect
- Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males by Giuliano, 2011 in N Engl J Med
- HPV vaccine against anal HPV infection and anal intraepithelial neoplasia by Palefsky, 2011 in N Eng J Med
- Population effectiveness, not efficacy, should decide who gets vaccinated against human papillomavirus via publicly funded programs by Castle, 2011 in J Infect Dis
- Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity by Brisson, 2011 in J Infect Dis
- Cost-effectiveness of human papillomavirus vaccination in the United States by Chesson, 2008 in Emerg Infect Dis
- Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States by Kim, 2009 in BMJ
- Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe by Marty, 2013 in BMC Cancer
- Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis by Kim, 2010 in Lancet Infect Dis
- Human papillomavirus vaccine and men: what are the obstacles and challenges? by Stupiansky, 2012 in Curr Opin Infect Dis
- HPV vaccine and males: issues and challenges by Zimet, 2010 in Gynecol Oncol
- Variables associated with human papillomavirus (HPV) vaccine acceptance by men by Ferris, 2009 in J Am Board Fam Med
- Acceptability of human papillomavirus vaccine for males: a review of the literature by Liddon, 2010 in Journal of Adolescent Health
- Predictors of HPV vaccine acceptability: a theory-informed, systematic review by Brewer, 2007 in Prev Med
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement by Moher, 2009 in PLoS Med
Citing the Source Article (APA)
Newman, P.A., Logie, C.H., Doukas, N., Asakura, K. (2013). HPV vaccine acceptability among men: a systematic review and meta-analysis. Sexually transmitted infections, 89(7), 568-574. 10.1136/sextrans-2012-050980
Key Findings: Acceptability Rates and Influencing Factors
The study, a systematic review and meta-analysis, delved into the rates of HPV vaccine acceptability among men. It revealed a weighted mean acceptability of 50.4 on a 100-point scale. This indicates a moderate level of acceptance, suggesting there’s room for improvement in HPV vaccine uptake among men.
Several factors were identified that influenced men’s acceptability of the HPV vaccine. Notably, perceived benefits of the vaccine, anticipatory regret, and healthcare provider recommendations played a significant role in shaping men’s attitudes towards the vaccine.
Implications for Public Health Campaigns
- Raising Awareness: Promoting positive attitudes towards the HPV vaccine and increasing awareness about HPV risks in men can boost vaccine acceptability.
- Healthcare Provider’s Role: Recommendations from healthcare providers can significantly influence men’s decision to get vaccinated.
- Addressing Barriers: Addressing cost and logistical barriers can further enhance vaccine uptake.
Looking Ahead: The Road to Improved Vaccine Uptake
While the study provides valuable insights, it also underscores the need for further research. Future investigations, especially intervention studies, can offer more concrete strategies to promote effective HPV vaccine uptake among men.
Given the health implications of HPV in men, including the risk of anal and penile cancers, it’s crucial to prioritize HPV vaccination for men. This not only benefits men but also contributes to the broader goal of herd immunity, protecting the community at large.
Considering the article’s nature as a systematic review and meta-analysis, it’s essential to evaluate its content using the PP-ICONS approach:
- Population: Men of varying ages and backgrounds.
- Intervention: HPV vaccination.
- Comparison: Factors influencing vaccine acceptability compared across different studies.
- Outcome: Acceptability rates and influencing factors.
- Numbers: 29 studies were included, with a total of 8360 participants.
- Study Design: Systematic review and meta-analysis.
What are your thoughts on the findings? How can we further enhance HPV vaccine uptake among men? Share your insights below!